NEUROBIOLOGY OF RAPID ACTING ANTIDEPRESSANTS – University of Maryland School of Medicine – Baltimore, MD USA
A postdoctoral position is available to study the synaptic mechanism of action underlying rapid antidepressant effects.
Our laboratory is broadly interested in using preclinical approaches to study mood disorder neurobiology, understand mechanism of drugs used to treat these conditions, and develop novel treatment approaches (see www.gouldlab.org; Zanos et al., Nature, 2016 May 4;533(7604):481-6). The current project will test novel hypotheses regarding mechanisms (on the levels of behavior, circuits, and synapses) that underlie therapeutic efficacy of rapid-acting antidepressant drugs, including ketamine and mechanistically novel drug candidates. Techniques to be utilized may include--but are not limited to--behavioral pharmacology, optogenetics, electrophysiology, electroencephalography (EEG), immunohistochemistry, transgenic mice, and classical pharmacology. Projects will have translational relevance. Strong writing and communication skills as well as proficiency in English are essential. The successful candidate will play a lead role in designing and executing projects, writing publications, and presenting data at professional conferences. Salary will be based on experience. Interested applicants with a PhD in neuroscience, pharmacology, or related disciplines should send a CV, statement of research interests and the names of 2-3 references to: Dr. Todd Gould, Departments of Psychiatry, Pharmacology, and Anatomy and Neurobiology, via e-mail: firstname.lastname@example.org.
PhD in neuroscience, pharmacology, or related disciplines
Additional Salary Information: Salary will be based on experience. NIH postdoc salary scale.